Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong · Delayed Price · Currency is HKD 5.50
-0.01 (-0.09%)
Sep 9, 2026, 6:07 PM HKT
Charmacy Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 530.1 | 753.6 | 563.15 | 634.2 | 492.67 | 630.17 |
Short-Term Investments | - | 11.05 | 10.7 | 10.56 | 11.13 | 11.59 |
Cash & Short-Term Investments | 530.1 | 764.65 | 573.86 | 644.76 | 503.81 | 641.76 |
Cash Growth | 1.71% | 33.25% | -11.00% | 27.98% | -21.50% | 6.60% |
Accounts Receivable | 1,518 | 1,261 | 1,226 | 965.35 | 865.26 | 731.26 |
Other Receivables | 14.98 | 50.02 | 43.12 | 41.49 | 116.91 | 42.8 |
Receivables | 1,533 | 1,311 | 1,270 | 1,007 | 982.17 | 774.06 |
Inventory | 902.28 | 796.25 | 655.91 | 775.84 | 586.85 | 509.16 |
Prepaid Expenses | - | - | 1.84 | - | - | - |
Other Current Assets | 579.36 | 688.95 | 528.84 | 384.56 | 389.53 | 313.25 |
Total Current Assets | 3,544 | 3,561 | 3,030 | 2,812 | 2,462 | 2,238 |
Property, Plant & Equipment | 282.69 | 294.57 | 317.6 | 328.55 | 294.08 | 348.44 |
Goodwill | 6 | 6 | 6 | 6.02 | 6.02 | 6.02 |
Other Intangible Assets | 66.23 | 68.33 | 72.49 | 76.72 | 80.86 | 143.03 |
Long-Term Deferred Tax Assets | 12.74 | 11.48 | 7.64 | 7.38 | 6.8 | 8.16 |
Long-Term Deferred Charges | 16.49 | 18.69 | 22.91 | 16.98 | 16.34 | 19.21 |
Total Assets | 3,929 | 3,960 | 3,457 | 3,248 | 2,866 | 2,763 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,294 | 894.06 | 826.51 | 936.49 | 876.78 | 809.77 |
Accrued Expenses | 5.56 | 66.98 | 61.29 | 58.35 | 86.48 | 47.84 |
Short-Term Debt | 1,241 | 1,762 | 1,350 | 1,338 | 1,166 | 1,193 |
Current Portion of Long-Term Debt | 13.52 | 4.25 | 1.22 | - | - | 31.78 |
Current Portion of Leases | - | 8.97 | 8.78 | 6.59 | 4.15 | 2.97 |
Finance Div. Other Current Liabilities | - | 0.23 | 0.2 | - | - | - |
Current Income Taxes Payable | 71.21 | 14.2 | 11.72 | 12.85 | 27.05 | 6.41 |
Current Unearned Revenue | 4.77 | 5.02 | 2.1 | 19.49 | 13.53 | 46.66 |
Other Current Liabilities | 635.54 | 525.65 | 526.3 | 247.55 | 81.98 | 20.44 |
Total Current Liabilities | 3,266 | 3,281 | 2,789 | 2,619 | 2,256 | 2,159 |
Long-Term Debt | 36 | 38.1 | 13.8 | - | - | 86.87 |
Long-Term Leases | 19.5 | 24.21 | 35.17 | 30.39 | 15.75 | 12.49 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.3 |
Long-Term Deferred Tax Liabilities | 0.41 | 0.19 | 0.38 | 0.6 | 0.06 | 0.4 |
Total Liabilities | 3,322 | 3,344 | 2,838 | 2,650 | 2,271 | 2,259 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 108 | 108 | 108 | 108 | 108 | 108 |
Additional Paid-In Capital | - | 278 | 278 | 278 | 278 | 278 |
Retained Earnings | 219.53 | 229.37 | 231.7 | 210.82 | 208.07 | 117.11 |
Comprehensive Income & Other | 278.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
Total Common Equity | 606.52 | 616.36 | 618.69 | 597.81 | 595.06 | 504.1 |
Shareholders' Equity | 606.52 | 616.36 | 618.69 | 597.81 | 595.06 | 504.1 |
Total Liabilities & Equity | 3,929 | 3,960 | 3,457 | 3,248 | 2,866 | 2,763 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,310 | 1,837 | 1,409 | 1,375 | 1,186 | 1,327 |
Net Cash (Debt) | -780.21 | -1,073 | -835.6 | -729.76 | -681.72 | -685.4 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.22 | -9.93 | -7.74 | -6.76 | -6.31 | -6.35 |
Filing Date Shares Outstanding | 108 | 108 | 108 | 108 | 108 | 108 |
Total Common Shares Outstanding | 108 | 108 | 108 | 108 | 108 | 108 |
Working Capital | 278.29 | 279.79 | 241.39 | 193.14 | 206.77 | 79.3 |
Book Value Per Share | 5.62 | 5.71 | 5.73 | 5.54 | 5.51 | 4.67 |
Tangible Book Value | 534.29 | 542.04 | 540.2 | 515.06 | 508.18 | 355.04 |
Tangible Book Value Per Share | 4.95 | 5.02 | 5.00 | 4.77 | 4.71 | 3.29 |
Buildings | - | 298.92 | 298.21 | 298.21 | 269.2 | 329.71 |
Machinery | - | 100.01 | 98.08 | 81.06 | 76.69 | 101.72 |